HER2 Support Group Forums - View Single Post - Synta second-quarter net loss increases to $9.1 million

News · 08-10-2010, 01:30 AM

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended June 30, 2010.

More...

08-10-2010, 01:30 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,976	Synta second-quarter net loss increases to $9.1 million Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended June 30, 2010. More...